Supply-chain management

Opportunity
July 2, 2018

Through the TSP Program, Baylor-Swaziland and Baylor-Malawi are implementing the Supply Chain and Pharmaceutical Assistance for Sustainable Systems (SC+PASS) Project in eSwatini.

Event
July 2, 2018

Satellite Session at the 22nd International AIDS Conference 2018 (AIDS 2018)
RAI Amsterdam, the Netherlands
Wednesday, July 25, 2018 | 7:00-8:30 am | Conference Room E102

Resource
June 25, 2018

In 2015, several condom manufacturers joined donor agencies to form a coalition whose main goal is to provide 20 billion condoms to low and middle-income countries by 2020.

Resource
May 15, 2018

A step-by-step framework for planning the introduction of PrEP

Building a program to introduce PrEP effectively requires action on many levels. Some steps need to be done in sequence, others can be done simultaneously.

Resource
April 11, 2018

Swaziland has one of the highest adult HIV prevalence rates worldwide, 27%; with approximately 200,000 people 15 years and older living with HIV. Swaziland and many other countries in sub-Saharan Africa have adopted universal test-and-treat (UTT) policies.

Resource
February 1, 2018

Condoms have long been an important tool in preventing not only the transmission of HIV and other sexually transmitted infections, but also preventing unwanted pregnancies. How can we expand these services and improve their usage?

Resource
November 22, 2017

Remarkable progress is being made on HIV treatment. Ahead of World AIDS Day, UNAIDS has launched a new report showing that access to treatment has risen significantly. In 2000, just 685 000 people living with HIV had access to antiretroviral therapy.

Resource
November 13, 2017

In late 2015, the Linkages Across the Continuum of HIV Services for Key Populations (LINKAGES) project established a global acceleration initiative to fast-track and strengthen delivery of a comprehensive package of health services for key populations (KPs) at scale. In this context, “acceleratio

Resource
October 26, 2017

Fungi are major contributors to the opportunistic infections that affect patients with HIV/AIDS.